Ultrasound-Guided Intermediate Versus Deep Cervical Plexus Block for Carotid Endarterectomy

April 27, 2023 updated by: Ozlem Turhan, Istanbul University

Efficacy of Ultrasound-Guided Intermediate Versus Deep Cervical Plexus Block for Carotid Endarterectomy: A Randomized Controlled Trial

Cervical plexus blocks are regional methods used in carotid endarterectomy. Cervical plexus blocks consist of three blocks: superficial, intermediate and deep. These three blocks can be used alone or combined. The aim of this study is to evaluate the effectiveness of ultrasound-guided intermediate and deed cervical plexus block in patients undergoing carotid endarterectomy.

Study Overview

Detailed Description

Carotid endarterectomy is a surgical method used to treat occlusive lesions of the carotid. Regional anesthesia is preferred because it allows for consciousness control and neurological examination during the operation. Cervical plexus blocks are regional methods used in carotid endarterectomy. It is a regional technique in which the cervical spinal nerves (C2-C3-C4) are blocked with a local anesthetic agent from different regions. Cervical plexus blocks consist of three blocks: superficial, intermediate and deep, depending on the depth at which the local anesthetic agent is infiltrated. According to the preference of the clinician for the purpose of anesthesia, these three blocks can be used separately or combined. It is mentioned that all three blocks provide sufficient anesthesia for carotid endarterectomy surgery to be performed.

In the study, investigators planned to evaluate the effectiveness of ultrasound-guided intermediate and deep cervical plexus blocks in patients undergoing carotid endarterectomy by comparing the number of patients who need additional local anesthetics.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Nükhet Sivrikoz
  • Phone Number: 31742 +902124142000
  • Email: ntsz06@gmail.com

Study Locations

      • Istanbul, Turkey
        • Istanbul Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients scheduled for carotid endarterectom y surgery.

Exclusion Criteria:

  • Local infection
  • Previous ipsilateral surgery
  • Radiotherapy
  • Conversion to general anesthesia
  • Known bleeding disorders
  • Known allergy of local anesthetic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group intermediate cervical plexus block (GI)
Patients anesthetized with intermediate cervical plexus block.
Intermediate cervical plexus block will be applied in transverse plane using posterior approach at C4.
Active Comparator: Group deep cervical plexus block (GD)
Patients anesthetized with deep cervical plexus block.
Deep cervical plexus block will be appliedin transverse plane using anterior approach at C2-3-4.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient needed supplemental local anesthetic
Time Frame: Intraoperative 2-3 hours
If patients complain about pain above visual analog scale 3, 4ml 1% lidocaine is injected by surgeon.
Intraoperative 2-3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Amount of supplemental local anesthetic
Time Frame: Intraoperative 2-3 hours
If patients complain about pain above visual analog scale 3, 4ml 1% lidocaine is injected by surgeon.
Intraoperative 2-3 hours
Duration of blocks' application
Time Frame: Up to 15 minutes
time from the insertion of probe to the removal of needle from skin
Up to 15 minutes
Region where patient needs supplemental local anesthetic
Time Frame: Intraoperative 2-3 hours
Region where supplemental lidocaine is injected by surgeon
Intraoperative 2-3 hours
Amount of remifentanil
Time Frame: Intraoperative 2-3 hours
Amount of remifentanil (0.02mcg/kg/min) infused during surgery for sedation.
Intraoperative 2-3 hours
Pain assessment
Time Frame: Intraoperative 2-3 hours
Pain assessment will be assessed using visual analog scale (VAS 0 to 10; 0: no pain, 10: the worst pain imaginable )
Intraoperative 2-3 hours
Complications
Time Frame: Up to 24 hours
Hematoma, dysphagia, hoarseness, facial paralysis, Horner's syndrome, intravascular or intrathecal injection
Up to 24 hours
Patient's satisfaction
Time Frame: Up to 24 hours
Likert scale:1-5 (1: very dissatisfied, 5: very satisfied)
Up to 24 hours
Surgeon's satisfaction
Time Frame: Up to 24 hours
Likert scale:1-5 (1: very dissatisfied, 5: very satisfied)
Up to 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 7, 2022

Primary Completion (Actual)

January 15, 2023

Study Completion (Actual)

April 27, 2023

Study Registration Dates

First Submitted

April 24, 2022

First Submitted That Met QC Criteria

April 28, 2022

First Posted (Actual)

April 29, 2022

Study Record Updates

Last Update Posted (Actual)

April 28, 2023

Last Update Submitted That Met QC Criteria

April 27, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/923

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia

Clinical Trials on Intermediate cervical plexus block

3
Subscribe